Paclitaxel–carboplatin for advanced or recurrent carcinosarcoma of the uterus: the Japan Uterine Sarcoma Group and Tohoku Gynecologic Cancer Unit Study

Tadao Takano(Tohoku University), Junzo Kigawa(Tottori University Hospital), Muneaki Shimada(Tokyo Metropolitan Ohtsuka Hospital), Nobuo Yaegashi(Tohoku University), Yoshihito Yokoyama(Hirosaki University), Takashi Matsumoto(Aso Iizuka Hospital), Kenji Nakahara(Yamagata University), Masafumi Toyoshima(Nippon Medical School Hospital), Hideki Tokunaga(Tohoku University), Satoru Nagase(Yamagata University), Shinya Sato(Tokuyama (Japan)), Hiroshi Nishiyama(Eli Lilly (United States)), Toshio Fujimoto(Akita University), Hidekazu Yamada(Fukushima Medical University), Masahiro Kagabu(Iwate Medical University), Hitoshi Niikura(Tohoku University), Tadahiro Shoji(Iwate Medical University), Toru Sugiyama(St Mary's Hospital), Naoki Sato(Akita University), Kiyoshi Ito(Japan Cancer Society), Yukihiro Terada(Akita University), Hirohisa Kurachi(Osaka Women's and Children's Hospital), Takeo Otsuki(Tohoku University), Toru Tase(Miyagi Prefectural Hospital Organization), Hiroki Utsunomiya(Tohoku University), Hideki Mizunuma(Fukushima Medical University), Shu Soeda(Fukushima Medical University)
International Journal of Clinical Oncology
January 6, 2014
Cited by 12


Related Papers